Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial - Frishberg, Y; Hayes, W; Shasha-Lavsky, H (Front Pediatr, 2024)